Cabot (NYSE:CBT) Announces Earnings Results, Beats Expectations By $0.01 EPS

Cabot (NYSE:CBT) announced its earnings results on Monday. The specialty chemicals company reported $1.67 EPS for the quarter, topping the consensus estimate of $1.66 by $0.01, FiscalAI reports. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same period last year, the company posted $1.90 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. Cabot updated its FY 2026 guidance to 6.150-6.450 EPS.

Cabot Stock Performance

NYSE CBT opened at $90.00 on Tuesday. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The firm’s fifty day moving average price is $88.03 and its two-hundred day moving average price is $79.56. The firm has a market capitalization of $4.65 billion, a P/E ratio of 17.01, a price-to-earnings-growth ratio of 11.46 and a beta of 0.84. Cabot has a 1 year low of $58.33 and a 1 year high of $94.53.

Cabot Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio is 35.73%.

Institutional Investors Weigh In On Cabot

Several hedge funds have recently added to or reduced their stakes in CBT. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Cabot by 5.6% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after buying an additional 124,613 shares during the last quarter. State Street Corp grew its position in shares of Cabot by 1.0% during the 4th quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after purchasing an additional 20,021 shares in the last quarter. Bank of America Corp DE grew its position in shares of Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after purchasing an additional 63,080 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Cabot by 6.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,663,283 shares of the specialty chemicals company’s stock worth $110,243,000 after purchasing an additional 106,521 shares during the period. Finally, Sei Investments Co. increased its holdings in shares of Cabot by 2.4% during the third quarter. Sei Investments Co. now owns 1,008,847 shares of the specialty chemicals company’s stock worth $76,722,000 after purchasing an additional 23,267 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CBT. JPMorgan Chase & Co. increased their price objective on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research report on Wednesday, May 13th. Truist Financial started coverage on Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 price target for the company. UBS Group raised their price target on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Finally, Mizuho boosted their price objective on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot presently has an average rating of “Hold” and a consensus target price of $85.80.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.